ADM At the 2022 New Nutrition Conference held recently, ADM not only brought sports nutrition "new force" raw materials, that is probiotics, but also gave a complete sports nutrition solution. ADM BPL1 Bifidobacterium lactis CECT8145 won the 2022 iSEE Global Food Technology Innovation Award. This … [Read more...] about HPA (China) News – August 2022
News in collaboration with our Partner HPA (China)
HPA (China) News – May 2022
Nuvozymes released the“Pylopass™ and Helicobacter pylori White Paper” Morinaga Milk's strain Bifidobacterium longum subsp. BB536 was approved for use in China infant food Morinaga Milk's strain Bifidobacterium infantis M-63 has obtained FDA's GRAS (Generally Recognized as Safe). Vland … [Read more...] about HPA (China) News – May 2022
HPA (China) News – April 2022
Probiotics China team interviewed Sacco CSL with its CEO for Asia-Pacific, Mr. John Goebel. Two Probiotics related products from AB-Biotics, the Lipigo and AB-21 won the 2022 Nutraingredients Awards. AB-Biotics presented its starter product Yogumel for making yogurt or kefir at the Alimentaria … [Read more...] about HPA (China) News – April 2022
HPA (China) News – March 2022
Novozymes conducted a comprehensive consumer survey in March, pointed out that in the post-epidemic era, consumers are more concerned about their physical and mental health, and are more inclined to choose natural and clean products. From the perspective of the consumer market, the categories … [Read more...] about HPA (China) News – March 2022
HPA (China) News – February 2022
Probiotics Online released the exclusive interview with Mr. Jordi Riera Alsina, the Chief Business Development Officer of AB-Biotics S.A: AB-Biotics Leads the Rise of Natural Probiotics. ADM released a report about future dietary supplement consumers, pointing out that 64% global consumers … [Read more...] about HPA (China) News – February 2022
HPA (China) News – January 2022
AB-Biotics published an article in the Journal Gut Microbes, "Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial". P The first product launched by YuanQiForest in 2022 was the DuiCe SODA Lactobacillus drink. It … [Read more...] about HPA (China) News – January 2022